Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic pathways in human heart failure.

Carmen C Sucharov1

  • 1Division of Cardiology, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Denver, CO 80262, USA. kika.sucharov@uchsc.edu

Expert Review of Cardiovascular Therapy
|December 26, 2006
PubMed
Summary

Beta-adrenergic receptor activation impacts heart failure. This review explores downstream signaling pathways, including PDE3, phospholamban phosphorylation, and CaMKII activation, as potential new targets for heart failure treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial and Cardiolipin Adaptations to Ventricular Assist Device Support in Pediatric Versus Adult Failing Myocardium.

bioRxiv : the preprint server for biology·2026
Same author

Circulating miRNA-Protein Signatures Predict Outcomes in Pediatric Dilated Cardiomyopathy.

bioRxiv : the preprint server for biology·2026
Same author

Age-dependent Transcriptional Programs Distinguish Pediatric from Adult Dilated Cardiomyopathy.

medRxiv : the preprint server for health sciences·2026
Same author

Investigating trophoblast invasion and angiogenesis expression changes in a caloric deficient mouse model of fetal growth restriction.

Reproductive biology·2026
Same author

Altered Arginine Metabolism in Children Undergoing Fontan Palliation: A Prospective Cohort Study.

Pulmonary circulation·2025
Same author

Human fetal circulating factors from pregnancies complicated by obesity upregulate genes associated with pathological hypertrophy in neonatal rat cardiomyocytes.

American journal of physiology. Heart and circulatory physiology·2025

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Beta-adrenergic receptor (BAR) activation is crucial in human heart failure (HF) progression.
  • Beta-blocker therapy has improved HF outcomes but an unmet need for novel therapeutic targets persists.
  • Understanding downstream signaling pathways of BAR stimulation is key for developing new HF treatments.

Purpose of the Study:

  • To review the significance of downstream signaling pathways activated by beta-adrenergic stimulation in the pathophysiology of heart failure.
  • To highlight potential therapeutic targets for heart failure based on these signaling pathways.

Main Methods:

  • Literature review focusing on studies analyzing downstream signaling pathways of beta-adrenergic stimulation in heart failure.
  • Detailed discussion of the roles of phosphodiesterase 3 (PDE3), phospholamban phosphorylation, and calcium/calmodulin-dependent protein kinase II (CaMKII) activation.

Related Experiment Videos

Main Results:

  • Beta-adrenergic stimulation activates specific downstream pathways implicated in heart failure.
  • PDE3, phospholamban phosphorylation, and CaMKII activation are identified as critical mediators in the context of beta-adrenergic signaling in HF.
  • These pathways represent promising targets for future heart failure therapeutics.

Conclusions:

  • Targeting specific downstream effectors of beta-adrenergic receptor activation, such as PDE3, phospholamban phosphorylation, and CaMKII, offers a promising avenue for novel heart failure therapies.
  • Further research into these pathways could lead to improved treatment strategies for patients with heart failure.